StonvexLoading…
StonvexStonvexStonvexCore line items from XRX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.02B | $6.22B | $6.89B | $7.11B |
Operating Income | Not available | Not available | Not available | $-328.00M |
Net Income | $-1.03B | $-1.32B | $1.00M | $-322.00M |
EPS (Diluted) | $-8.25 | $-10.75 | $-0.09 | $-2.15 |
Total Assets | $9.82B | $8.37B | $10.01B | $11.54B |
Total Liabilities | $9.15B | $7.06B | $7.24B | $7.97B |
Cash & Equivalents | $512.00M | $576.00M | $519.00M | $1.04B |
Free Cash Flow OCF − CapEx | $187.00M | $484.00M | $657.00M | $123.00M |
Shares Outstanding | 128.04M | 124.44M | 123.14M | 155.78M |